Publications by authors named "Michael Ewer"

Claim this Profile
I
Is the pendulum slowly starting to swing back?
Michael S Ewer, Jay Herson

Cardiooncology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arrhythmia in Bruton Tyrosine Kinase Inhibitor-Treated Patients: Unanswered Questions.
Michael S Ewer, Steven M Ewer

Chemotherapy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?
Michael S Ewer, Nicolas L Palaskas, Jay Herson

J Pharmacol Exp Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Case reports in cardio-oncology: 2022.
Michael S Ewer, Syed Wamique Yusuf, Reto Asmis, Jun-Ichi Abe

Front Cardiovasc Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential and Pitfalls of Pharmacovigilance Databases in Oncology.
Ilana Schlam, Michael S Ewer, Sandra M Swain

JACC CardioOncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could Some Reports of Trastuzumab Cardiotoxicity Be a Surveillance Artifact?
Michael S Ewer, Sandra M Swain

J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.
Michael S Ewer, Jay Herson

Cardiooncology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
Chau Dang, Michael S Ewer, Suzette Delaloge, Jean-Marc Ferrero, Ramon Colomer

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective on the Cardiotoxicity of Third-Generation Targeted EGFRs in the Treatment of NSCLC.
Michael S Ewer, Steven M Ewer

JTO Clin Res Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to K. Anand et al and K. Kunimasa.
Michael S Ewer

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients.
Dominique J Monlezun, Logan Hostetter, Prakash Balan, Nicolas Palaskas, Juan Lopez-Mattei, Michael Ewer

Cardiooncology· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
Martine Piccart, Marion Procter, Debora Fumagalli, Evandro de Azambuja, Emma Clark, Michael S Ewer

J Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, Evandro de Azambuja, Frances Boyle, Michael S Ewer

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Safety of Osimertinib: A Review of Data.
Michael S Ewer, Sri Harsha Tekumalla, Andrew Walding, Kwame N Atuah

J Clin Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020.
Anecita P Fadol, Nicolas L Palaskas, Michael S Ewer, Anita Deswal

Cardiooncology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
Daniel Eiger, Noam F Pondé, Dominique Agbor-Tarh, Alvaro Moreno-Aspitia, Martine Piccart, Michael S Ewer

Br J Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer patients in cardiology: how to communicate with patients with special psychological needs and manage their cardiac problems in daily clinical practice.
Chiara Lestuzzi, Maria Antonietta Annunziata, Anju Nohria, Barbara Muzzatti, Irma Bisceglia, Michael S Ewer

J Cardiovasc Med (Hagerstown)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Edward T H Yeh, Michael S Ewer, Javid Moslehi, Monika Dlugosz-Danecka, Jose Banchs

Semin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Old and new directions of Cardio-Oncology.
Michael S Ewer, Joseph R Carver, Giorgio Minotti

Semin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helping the cardio-oncologist: from real life to guidelines.
Saro H Armenian, Wojciech Jurczak, Joseph R Carver, Alessandra Gennari, Giorgio Minotti, Michael S Ewer

Semin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Cardiotoxicity After Anthracycline Exposure Constitutes a Complex and Clinically Important Entity.
Michael S Ewer, Steven M Ewer

JACC Heart Fail· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False Positive Cardiotoxicity Events in Cancer-Related Clinical Trials: Risks Related to Imperfect Noninvasive Parameters.
Michael S Ewer, Jay Herson

Chemotherapy· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.
Bruce D Cheson, Susan O'Brien, Michael S Ewer, Marcus D Goncalves, Azeez Farooki

Clin Lymphoma Myeloma Leuk· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
Jennifer R Brown, Javid Moslehi, Michael S Ewer, Susan M O'Brien, Paolo Ghia

Br J Haematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).
Noam Ponde, Ian Bradbury, Matteo Lambertini, Michael Ewer, Christine Campbell

Breast Cancer Res Treat· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis